Literature DB >> 9836645

Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.

T Yujiri1, S Sather, G R Fanger, G L Johnson.   

Abstract

Targeted disruption of the gene encoding MEK kinase 1 (MEKK1), a mitogen-activated protein kinase (MAPK) kinase kinase, defined its function in the regulation of MAPK pathways and cell survival. MEKK1(-/-) embryonic stem cells from mice had lost or altered responses of the c-Jun amino-terminal kinase (JNK) to microtubule disruption and cold stress but activated JNK normally in response to heat shock, anisomycin, and ultraviolet irradiation. Activation of JNK was lost and that of extracellular signal-regulated protein kinase (ERK) was diminished in response to hyperosmolarity and serum factors in MEKK1(-/-) cells. Loss of MEKK1 expression resulted in a greater apoptotic response of cells to hyperosmolarity and microtubule disruption. When activated by specific stresses that alter cell shape and the cytoskeleton, MEKK1 signals to protect cells from apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836645     DOI: 10.1126/science.282.5395.1911

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  85 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export.

Authors:  S H Hong; M L Privalsky
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

Authors:  Bruce D Cuevas; Amy N Abell; James A Witowsky; Toshiaki Yujiri; Nancy Lassignal Johnson; Kamala Kesavan; Marti Ware; Peter L Jones; Scott A Weed; Roberta L DeBiasi; Yoshitomo Oka; Kenneth L Tyler; Gary L Johnson
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 4.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

5.  Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms.

Authors:  L Butterfield; E Zentrich; A Beekman; L E Heasley
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

6.  Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation.

Authors:  Clare C Davies; Atanu Chakraborty; Filippo Cipriani; Katharina Haigh; Jody J Haigh; Axel Behrens
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 7.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

8.  MEKK1 Associated with Neuronal Apoptosis Following Intracerebral Hemorrhage.

Authors:  Hongjian Lu; Xiaojin Ning; Xuelei Tao; Jianbing Ren; Xinjian Song; Weidong Tao; Liang Zhu; Lijian Han; Tao Tao; Jianbin Yang
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

9.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

Authors:  Junichi Sadoshima; Olivier Montagne; Qian Wang; Guiping Yang; Jill Warden; Jing Liu; Gen Takagi; Vijaya Karoor; Chull Hong; Gary L Johnson; Dorothy E Vatner; Stephen F Vatner
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Cyclin D2 is a critical mediator of exercise-induced cardiac hypertrophy.

Authors:  Stephen W Luckey; Chris D Haines; John P Konhilas; Elizabeth D Luczak; Antke Messmer-Kratzsch; Leslie A Leinwand
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.